Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson
MWN-AI** Summary
Tactile Systems Technology, Inc. (Tactile Medical; Nasdaq: TCMD) announced the appointment of Andrea Pearson to its Board of Directors, effective March 9, 2026. Pearson, a seasoned executive with over 25 years of healthcare experience, brings extensive expertise in scaling organizations and driving growth, enhancing the Board's strategic capabilities.
Most recently, Pearson was Growth Advisor and Chief Marketing Officer at Harbor Health, where she integrated clinical care with health insurance. Previously, as Chief Growth Officer at DispatchHealth, she successfully developed strategies that expanded the company's market presence from two to over 50 U.S. markets, leading to a remarkable 30-fold revenue increase. Her prior experience includes multiple executive positions at HealthGrades, where, as Chief Marketing Officer, she significantly increased the platform's consumer audience.
Bill Burke, Chairman of the Board of Tactile Medical, expressed enthusiasm about Pearson's appointment, highlighting her proven success in driving growth and innovation in healthcare. He emphasized that her insights into patient engagement would be critical as Tactile Medical further solidifies its market leadership in treating lymphatic dysfunction and airway clearance.
Tactile Medical specializes in developing and marketing at-home therapies for patients facing chronic conditions such as lymphedema, lipedema, chronic venous insufficiency, and chronic inflammatory lung disease. The company's mission is to empower patients to improve their quality of life while helping clinicians enhance care access and reduce overall healthcare costs.
Pearson’s addition to the board is expected to bolster Tactile Medical's commitment to innovation and growth, benefiting both the company and the communities it serves. As Tactile continues to expand its impact, Pearson’s expertise will be invaluable in navigating the complexities of the healthcare ecosystem.
MWN-AI** Analysis
Tactile Medical (Nasdaq: TCMD) recently made a strategic move by appointing Andrea Pearson to its Board of Directors. This decision is significant for investors, as it highlights the company's commitment to growth and innovation within the healthcare technology sector, particularly in providing therapies for chronic conditions like lymphedema and chronic lung diseases. Pearson's extensive experience with scaling healthcare organizations and her proven track record in growth strategy make her a valuable asset during a period where patient engagement and effective marketing are critical.
Andrea Pearson’s background as Chief Marketing Officer and Chief Growth Officer at DispatchHealth and her role with Harbor Health suggest she will prioritize robust patient-oriented strategies, which could enhance Tactile Medical's brand visibility and market presence. The healthcare industry increasingly relies on effective communication and customer acquisition, especially amid shifting policies and consumer expectations. Pearson’s expertise in these areas stands to benefit Tactile Medical significantly as it seeks to expand its market leadership.
The appointment signals Tactile Medical’s intentions to not only strengthen its existing therapeutic offerings but also potentially broaden its scope into new markets through innovative product development and better alignment with healthcare providers and patients. Investors should monitor how Tactile Medical utilizes Pearson's expertise to drive both revenue and patient engagement.
Furthermore, Pearson’s position on the Compliance & Reimbursement and Nominating & Corporate Governance Committees places her in a pivotal role concerning regulatory navigation and strategic oversight, essential for sustainable growth in the medical technology sector. For investors, this could enhance confidence in Tactile Medical’s strategic direction, potentially bolstering its stock performance in the coming quarters. Overall, Tactile Medical appears well-positioned for significant growth, making it an attractive option for investors seeking opportunities in the healthcare technology space.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
MINNEAPOLIS, March 09, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Andrea Pearson to the Company’s Board of Directors (“Board”) and as a member of the Compliance & Reimbursement and Nominating & Corporate Governance Committees, effective March 9, 2026.
Ms. Pearson is an accomplished senior executive and growth strategist with deep expertise in scaling healthcare organizations. Her extensive experience spans more than 25 years and includes exposure to product development, customer acquisition, branding, marketing communications, and public relations.
Most recently, she served as Growth Advisor and Chief Marketing Officer at Harbor Health, a healthcare organization that integrates clinical care with health insurance coverage. Previously, she was Chief Growth Officer, and, before that, Chief Marketing Officer at DispatchHealth, a leader in at-home, hospital-level care, where she architected the company’s growth strategy, scaling the business from two to more than 50 U.S. markets while driving a 30x increase in revenue. Prior to DispatchHealth, Ms. Pearson held multiple executive roles at HealthGrades, a leading online platform connecting patients with healthcare providers, including Chief Marketing Officer and Executive Vice President and General Manager. As Chief Marketing Officer, she grew the consumer audience from one million monthly to one million daily visitors. Her earlier career experience includes 10 years of increasing responsibility across product development, marketing, and general management roles.
“We are delighted to welcome Andrea to our Board of Directors,” said Bill Burke, Chairman of the Board of Tactile Medical. “Her strong track record driving growth and innovation, combined with her deep understanding of how patients engage within the healthcare ecosystem, will be invaluable as we continue to strengthen our market leadership positions in both lymphatic dysfunction and airway clearance.”
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic inflammatory lung disease by helping them live better and care for themselves. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
FAQ**
How will Andrea Pearson's extensive background in healthcare marketing and growth strategy impact Tactile Systems Technology Inc. TCMD’s future product development and market expansion initiatives?
What specific goals does Tactile Systems Technology Inc. TCMD have in place for enhancing its market leadership in lymphatic dysfunction and airway clearance following Andrea Pearson's appointment to the Board?
How does Tactile Systems Technology Inc. TCMD plan to leverage Andrea Pearson's experience with patient engagement to improve the customer acquisition process for its therapies?
In what ways does Tactile Systems Technology Inc. TCMD expect Andrea Pearson to contribute to the Compliance & Reimbursement and Nominating & Corporate Governance Committees in alignment with the company's growth strategy?
**MWN-AI FAQ is based on asking OpenAI questions about Tactile Systems Technology Inc. (NASDAQ: TCMD).
NASDAQ: TCMD
TCMD Trading
-3.84% G/L:
$27.26 Last:
56,709 Volume:
$28.34 Open:
